VIDEO: Triamcinolone acetonide an option in those with uveitic macular edema, IOP issues
Click Here to Manage Email Alerts
In this Healio Video Perspective from the ASRS meeting, Danny Mammo, MD, of Cole Eye Institute discusses the real-world effect of triamcinolone acetonide on IOP in patients with uveitic macular edema.
The multicenter retrospective review included 60 eyes of 54 patients who had a history of glaucoma, ocular hypertension or steroid response. Of 26 patients with prior steroid IOP response without incisional glaucoma surgery, 70% did not experience an IOP rise at first follow-up after one suprachoroidal injection of triamcinolone acetonide.
“We think these results are significant because they show that suprachoroidal steroid injection may be a safer, but not completely safe, alternative in these high-risk patients with IOP issues that have uveitic macular edema,” Mammo said.
Collapse
Mammo D. Intraocular pressure outcomes following suprachoroidal triamcinolone acetonide in patients with glaucoma, ocular hypertension, or steroid response. Presented at: American Society of Retina Specialists annual meeting; July 17-20, 2024; Stockholm.
Read more about
Click Here to Manage Email Alerts